Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
259
259 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- co-administration of aztreonamPhase 32 trials
Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia
- co-administration of cefepimePhase 32 trials
Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia
- DTGPhase 32 trials
Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Infection, Human Immunodeficiency Virus, HIV Infections
- FosmanogepixPhase 32 trials
Basilea Pharmaceutica · Candidemia, Candidiasis, Invasive, Invasive Mold Infections
- FTCPhase 32 trials
Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Infection, Human Immunodeficiency Virus
- GP681Phase 32 trials
Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza
- GP681 SimulantPhase 32 trials
Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza
- HepalatideL47, HLTPhase 32 trials
Shanghai HEP Pharmaceutical Co., Ltd. · Hepatitis D, Chronic, Hepatitis D
- HRS-5635Phase 32 trials
Fujian Shengdi Pharmaceutical Co., Ltd. · Chronic Hepatitis B, Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
- HRS-8427Phase 32 trials
Jiangsu HengRui Medicine Co., Ltd. · Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP), Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)
- HSK31679Phase 32 trials
Haisco Pharmaceutical Group Co., Ltd. · MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH (Non-Alcoholic Steatohepatitis), Non-Alcoholic Steatohepatitis (NASH)
- Human Diploid CellInactivated Hepatitis A Vaccine, HealivePhase 32 trials
Sinovac Biotech Co., Ltd · Hepatitis A Vaccine, Rabies Prevention
- ibuzatrelvirPF-07817883Phase 32 trials
Pfizer · COVID-19 SARS-CoV-2 Infection, COVID-19 Infection
- IIV-HDstandalonePhase 32 trials
Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization
- Inactivated Polio vaccinePhase 32 trials
LG Chem · Diphtheria, Tetanus, Pertussis
- MG1111BARICELA, Barycela inj.Phase 32 trials
Green Cross Corporation · Varicella, Varicella (Chickenpox), Chickenpox Vaccine
- MTBVACBBV169Phase 32 trials
Biofabri, S.L · Tuberculosis, Tuberculosis (TB)
- nacubactamPhase 32 trials
Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia
- OBRPhase 32 trials
Gilead Sciences · HIV-1-infection
- OlorofimF901318Phase 32 trials
F2G Ltd · Coccidioidomycosis, Disseminated Fungal Infection, Coccidioides Infection
- PTM FPhase 32 trials
Gilead Sciences · Pre-Exposure Prophylaxis of HIV Infection
- PTM LENPhase 32 trials
Gilead Sciences · Pre-Exposure Prophylaxis of HIV Infection
- RSVPreF3 OA vaccinePhase 32 trials
GSK · Respiratory Syncytial Virus Infections
- RVX000222apabetalone, RVX-208Phase 32 trials
Resverlogix Corp · Post-Acute COVID-19 Syndrome, Kidney Failure, Chronic
- su vaccineRZVPhase 32 trials
GSK · Herpes Zoster, Respiratory Syncytial Virus (RSV)
- TB-PPDPurified Protein Derivative of TuberculinPhase 32 trials
Chengdu CoenBiotech Co., Ltd · Tuberculosis, Latent Tuberculosis Infection
- TDFPhase 32 trials
Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, Chronic Hepatitis B Infection
- TestofenPhase 32 trials
RDC Clinical Pty Ltd · Long Covid19, Erectile Dysfunction
- TMPSMX, Trimethoprim-sulfamethoxazolePhase 32 trials
Locus Biosciences · Urinary Tract Infections, Candidemia, Mycoses
- TNM001Phase 32 trials
Zhuhai Trinomab Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections
- VYD2311Phase 32 trials
Invivyd, Inc. · Long COVID, COVID-19 (SARS-CoV-2 Infection), COVID 19 Vaccine
- zelicapavirPhase 32 trials
Enanta Pharmaceuticals, Inc · RSV, RSV Infection, Respiratory Syncytial Virus (RSV)
- ZiresovirAK0529Phase 32 trials
Shanghai Ark Biopharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections, Respiratory Synctial Virus Infections
- ZSP1273Phase 32 trials
Guangdong Raynovent Biotech Co., Ltd · Influenza A, Influenza a
- ADC189Phase 31 trial
Jiaxing AnDiCon Biotech Co.,Ltd · Influenza Type A, Influenza Type B
- BK1803Phase 31 trial
Tanabe Pharma Corporation · Pertussis, Diphtheria, Tetanus
- BMS-663068Phase 31 trial
GSK · HIV Infections
- BRC-201TG-1000, Pixavir MarboxilPhase 31 trial
Boryung Biopharma Co., Ltd. · Influenza
- DAS181Phase 31 trial
Ansun Biopharma, Inc. · Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised
- DWC202301Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects
- GC5103Undiluted .-Hepabig inj, Diluted .-Hepabig injPhase 31 trial
GC Biopharma Corp · Hepatitis B
- IVA337LanifibranorPhase 31 trial
Inventiva Pharma · NASH - Nonalcoholic Steatohepatitis
- LibevitugPhase 31 trial
Huahui Health · Chronic Hepatitis D Infection
- LMN-201Phase 31 trial
Lumen Bioscience, Inc. · Clostridioides Difficile Infection
- LYB005Phase 31 trial
Guangzhou Patronus Biotech Co., Ltd. · Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection, RSV Vaccine
- MolnupiravirMK-4482, LAGEVRIOPhase 31 trial
Merck & Co. · Coronavirus Disease (COVID-19)
- mRNA-1018-H5Phase 31 trial
Moderna · Influenza
- NVXC19EU licensed, standalonePhase 31 trial
Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization
- PCV13iPhase 31 trial
CanSino Biologics Inc. · Pneumococcal Infections, Streptococcal Infections, Bacterial Infections
- PLG0206Phase 31 trial
Peptilogics · Prosthetic-joint Infection
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.